Biochemical Remodeling of Purine Metabolism and Lipid Peroxidation Across Thyroid Disease Phenotypes

Ernur Kasipovich Bekov, Olga Anatolyevna Ponamareva, Ryszhan Y. Bakirova, Vilen Molotov-Luchanskiy, Nazgul Omarbekova, Khamida R. Abdikadirova, Azamat Kharin, Yelena Pozdnyakova

Metabolites, 2026

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.3390/metabo16100700
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Background and Objectives: Purine-metabolism profiles across distinct thyroid phenotypes remain poorly characterized despite the recognized redox imbalance associated with thyroid dysfunction and autoimmune thyroiditis (AIT). We compared plasma and erythrocyte purine-metabolite profiles, derived purine ratios, and their associations with lipid peroxidation across four thyroid-disease phenotypes and healthy controls. Materials and Methods: This single-center cross-sectional study included 164 participants: hypothyroidism without AIT (n = 31), AIT with hypothyroidism (n = 30), nontoxic nodular goiter with euthyroidism (n = 42), euthyroid AIT (n = 37), and healthy controls (n = 24). Purine metabolites were assessed by direct UV spectrophotometry and expressed in relative extinction units; thiobarbituric acid-reactive substances (TBARS)-derived malondialdehyde (MDA) equivalents were measured in plasma and erythrocytes. Results: Plasma guanine and hypoxanthine were lower in AIT with hypothyroidism than in hypothyroidism without AIT and in euthyroid AIT than in nontoxic nodular goiter. Plasma X/HX and UA/HX were higher in both AIT groups than in controls. Plasma MDA was elevated in all thyroid-disease groups, whereas erythrocyte MDA was highest in hypothyroidism without AIT. Plasma UA/X correlated positively with both plasma and erythrocyte MDA, and plasma UA/HX with plasma MDA, with phenotype-dependent heterogeneity in stratified analyses. Conclusions: Thyroid phenotypes showed distinct compartment-specific purine and lipid-peroxidation patterns rather than a uniform AIT-dependent shift. Purine ratios should be interpreted as indirect, method-specific indices rather than direct measures of metabolic flux or XOR/XO/XDH activity.